172 related articles for article (PubMed ID: 8262049)
21. Structure and function of vav.
Romero F; Fischer S
Cell Signal; 1996 Dec; 8(8):545-53. PubMed ID: 9115846
[TBL] [Abstract][Full Text] [Related]
22. Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.
Almarza E; Segovia JC; Guenechea G; Gómez SG; Ramírez A; Bueren JA
Exp Hematol; 2004 Apr; 32(4):360-4. PubMed ID: 15050746
[TBL] [Abstract][Full Text] [Related]
23. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
24. Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins.
Bustelo XR; Suen KL; Michael WM; Dreyfuss G; Barbacid M
Mol Cell Biol; 1995 Mar; 15(3):1324-32. PubMed ID: 7862126
[TBL] [Abstract][Full Text] [Related]
25. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells.
Platanias LC; Sweet ME
J Biol Chem; 1994 Feb; 269(5):3143-6. PubMed ID: 7508909
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic commitment during embryonic stem cell differentiation in culture.
Keller G; Kennedy M; Papayannopoulou T; Wiles MV
Mol Cell Biol; 1993 Jan; 13(1):473-86. PubMed ID: 8417345
[TBL] [Abstract][Full Text] [Related]
27. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.
Ogilvy S; Metcalf D; Gibson L; Bath ML; Harris AW; Adams JM
Blood; 1999 Sep; 94(6):1855-63. PubMed ID: 10477714
[TBL] [Abstract][Full Text] [Related]
28. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells.
Kon-Kozlowski M; Pani G; Pawson T; Siminovitch KA
J Biol Chem; 1996 Feb; 271(7):3856-62. PubMed ID: 8632004
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
Machide M; Mano H; Todokoro K
Oncogene; 1995 Aug; 11(4):619-25. PubMed ID: 7651724
[TBL] [Abstract][Full Text] [Related]
30. Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1.
Whetton AD; Lu Y; Pierce A; Carney L; Spooncer E
Blood; 2003 Oct; 102(8):2798-802. PubMed ID: 12829605
[TBL] [Abstract][Full Text] [Related]
31. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
32. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein.
Gulbins E; Coggeshall KM; Langlet C; Baier G; Bonnefoy-Berard N; Burn P; Wittinghofer A; Katzav S; Altman A
Mol Cell Biol; 1994 Feb; 14(2):906-13. PubMed ID: 8289830
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes.
Schuebel KE; Bustelo XR; Nielsen DA; Song BJ; Barbacid M; Goldman D; Lee IJ
Oncogene; 1996 Jul; 13(2):363-71. PubMed ID: 8710375
[TBL] [Abstract][Full Text] [Related]
34. c-fes expression in ontogenetic development and hematopoietic differentiation.
Carè A; Mattia G; Montesoro E; Parolini I; Russo G; Colombo MP; Peschle C
Oncogene; 1994 Mar; 9(3):739-47. PubMed ID: 8108116
[TBL] [Abstract][Full Text] [Related]
35. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity.
Shigematsu H; Iwasaki H; Otsuka T; Ohno Y; Arima F; Niho Y
J Biol Chem; 1997 May; 272(22):14334-40. PubMed ID: 9162069
[TBL] [Abstract][Full Text] [Related]
36. Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells.
Bertagnolo V; Marchisio M; Brugnoli F; Bavelloni A; Boccafogli L; Colamussi ML; Capitani S
Cell Growth Differ; 2001 Apr; 12(4):193-200. PubMed ID: 11331248
[TBL] [Abstract][Full Text] [Related]
37. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of expression of ets-1 and fli-1 proto-oncogenes in murine embryonic stem cells, induced to differentiation by retinoic acid].
Iakubovich EI; Evtushenko VI
Mol Biol (Mosk); 1999; 33(5):861-5. PubMed ID: 10579191
[No Abstract] [Full Text] [Related]
39. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.
Kim WI; Wiesner SM; Largaespada DA
Exp Hematol; 2007 Aug; 35(8):1231-9. PubMed ID: 17560009
[TBL] [Abstract][Full Text] [Related]
40. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.
Methia N; Louache F; Vainchenker W; Wendling F
Blood; 1993 Sep; 82(5):1395-401. PubMed ID: 7689867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
